| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
30,214 | 10,085 | |||||
General and administrative | ||||||
8,954 | 2,034 | |||||
Total operating expenses | ||||||
39,168 | 12,119 | |||||
Loss from operations | ||||||
-39,168 | -12,119 | |||||
Interest income, net | ||||||
2,188 | 806 | |||||
Interest expense | ||||||
- | 957 | |||||
Change in fair value of derivative liability | ||||||
- | -206 | |||||
Net loss | ||||||
-36,980 | -12,476 | |||||
Other comprehensive income/ (loss): | ||||||
Unrealized gain / (loss) on available for sales securities | ||||||
109 | -49 | |||||
Total comprehensive loss | ||||||
-36,871 | -12,525 | |||||
Net loss per share - basic and diluted | ||||||
-1.94 | -3.71 | |||||
Weighted average shares of common stock outstanding - basic and diluted | ||||||
19,031 | 3,362 | |||||